Ultralife Corporation
NASDAQ:ULBIElectrical Equipment & Parts
+$0.08 today
- Market cap
- $261.13M
- Beta
- 0.76
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.49
Volume 0.10M
Average 0.05M
ULBI Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Ultralife CorporationNASDAQ: ULBI
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses grows in line with its trailing trend
Q1 FY2026 operating expenses of $10.06M rose 12.5% year over year, in line with the +12.6% change in trailing-twelve-month operating expenses. Sequentially, it rose 11.7% from the prior quarter. Over 3 fiscal years it compounded at +6.4% a year.
Context
- Operating expenses amounted to 18.5% of revenue in FY2025, down 1.2 pp from a year earlier.
- Operating expenses increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +12.5% toward the trailing-twelve-month pace of +12.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 35.28M USD
- Year-over-year change
- +9.1%
- 4-year CAGR
- +9.4%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 35.28M | +9.1% |
| FY2024 | 2024-12-31 | 32.35M | +8.8% |
| FY2023 | 2023-12-31 | 29.73M | +1.6% |
| FY2022 | 2022-12-31 | 29.27M | +19.0% |
| FY2021 | 2021-12-31 | 24.61M | — |
Operating Expenses vs competitors
How ULBI compares with its peers on the latest reported figures
- ULBI's LTM Mar 2026 operating expenses of $38.15M is the 2nd highest of the 7 companies compared; the peer median is $17.54M.
- Its year-over-year change of +12.6% is the 4th highest of 7, against a peer median of +16.9%.
- Operating expenses amounts to 20.3% of revenue for ULBI, versus a peer median of 71.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $40.15M | +24.9% | +7.8% | 17.5% | |
| LTM Mar 2026 | $38.15M | +12.6% | +6.4% | 20.3% | |
| LTM Jan 2026 | $31.81M | +36.6% | +2.8% | 925.6% | |
| LTM Mar 2026 | $21.3M | -28.8% | +9.2% | 71.7% | |
| FY2026 | $13.79M | +256.9% | +56.8% | — | |
| LTM Mar 2026 | $11.89M | +8.9% | +138.8% | 724.2% | |
| LTM Mar 2026 | $4.68M | +4.3% | +4.9% | 11.1% | |
| Peer median (excluding ULBI) | $17.54M | +16.9% | +8.5% | 71.7% | |
Competitors are the stored peer set for ULBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 98.27M | 131.84M | 158.64M | 164.46M | 191.16M |
| Cost of Revenue | 73.63M | 102.44M | 119.44M | 122.14M | 146.66M |
| Gross Profit | 24.64M | 29.4M | 39.2M | 42.31M | 44.5M |
| Gross Margin | 25.1% | 22.3% | 24.7% | 25.7% | 23.3% |
| Research & Development | 6.83M | 7.08M | 7.53M | 8.27M | 9M |
| Selling, General & Admin | 17.78M | 22.19M | 22.19M | 24.08M | 26.28M |
| Operating Expenses | 24.61M | 29.27M | 29.73M | 32.35M | 35.28M |
| Depreciation & Amortization | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M |
| EBITDA | 3.63M | 4.96M | 15.04M | 14.4M | 1.05M |
| EBITDA Margin | 3.7% | 3.8% | 9.5% | 8.8% | 0.6% |
| Operating Income | 35K | 129K | 9.48M | 9.97M | 9.22M |
| Operating Margin | 0.0% | 0.1% | 6.0% | 6.1% | 4.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 242K | 951K | 2.02M | 1.94M | 3.95M |
| Other Income / Expenses | (186K) | (575K) | (358K) | (1.66M) | (17.62M) |
| Income Before Tax | (151K) | (446K) | 9.12M | 8.3M | (8.4M) |
| Pre-Tax Margin | -0.2% | -0.3% | 5.7% | 5.0% | -4.4% |
| Income Tax Expense | 79K | (326K) | 1.95M | 1.89M | (2.45M) |
| Net Income | (234K) | (119K) | 7.2M | 6.31M | (5.9M) |
| Net Margin | -0.2% | -0.1% | 4.5% | 3.8% | -3.1% |
| EPS (Basic) | (0.01) | (0.01) | 0.44 | 0.38 | (0.35) |
| EPS (Diluted) | (0.01) | (0.01) | 0.44 | 0.38 | (0.35) |
| Weighted Avg Shares | 16.04M | 16.13M | 16.36M | 16.56M | 16.64M |
| Weighted Avg Shares (Diluted) | 16.04M | 16.13M | 16.23M | 16.77M | 16.64M |
Ultralife Corporation
NASDAQ:ULBI
Intrinsic Alpha fair value
Locked
Current Price
$15.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.